ECE2016 Eposter Presentations Diabetes therapy (44 abstracts)
The need of change in the treatment options for diabetes in acute ischemic stroke
Baburhan Guldiken 1 , Burak Celik 1 , Merve Namli 1 , Buket Yilmaz Bulbul 2 , Mehmet Celik 2 & Sibel Guldiken 2
1Trakya University Medical Faculty, Department of Neurology, Edirne, Turkey; 2Trakya University Medical Faculty, Department of Internal Medicine, Division of Endocrinology, Edirne, Turkey.
Diabetes that is an important risk factor for ischemic stroke should also be well-treated in acute ischemic stroke patients for the secondary prevention against the next strokes. In the present study, we investigated the rate of the treatment changes in diabetic acute ischemic stroke patients during their stay at hospital.
One hundred twelve acute diabetic ischemic stroke patients that were hospitalized in the university neurology clinic were retrospectively evaluated. HbA1c levels and the need of changes in antidiabetic drugs and doses were noted.
Mean HbA1c levels were 8.2±2.2%. In order to better regulate the blood glucose levels, changes in the antidiabetic drugs had been made in 26.8% of patients. Change of dosage was found necessary in 33.9% of patients. Use of insulin that was seen 29% of patients increased to 37% at the time of discharge from hospital.
Diabetes was found undertreated before acute ischemic stroke. The need of change in the diabetes treatment was observed in a significant ratio of the patients. The neurologists who manage the treatment of the primary disease should also be alert for the need of changes in the treatment of diabetes.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more